2022 – J Exp Clin Cancer Res – Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells. – Pescatori S et al.- Read more…
2022 – J Exp Clin Cancer Res – Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells. – Pescatori S et al.- Read more…
We use cookies to make sure you can have the best browsing experience on our site. This site uses technical, session, profiling and third-party cookies for functions such as: answering your questions, sharing on social networks, viewing media, or direct or indirect marketing. For more information and to know how to disable them from your browser consult our Cookie Policy.